<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Classification of juvenile idiopathic arthritis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Classification of juvenile idiopathic arthritis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Classification of juvenile idiopathic arthritis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Marisa Klein-Gitelman, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Suzanne C Li, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elizabeth TePas, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 30, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Juvenile arthritis is a heterogeneous group of inflammatory disorders. The classification categories created for juvenile idiopathic arthritis (JIA) are primarily intended for research use and are not intended for use as diagnostic criteria [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         This topic reviews the classification categories for JIA. The individual disease categories are discussed in greater detail separately.
        </p>
        <p class="headingAnchor" id="H2346350370">
         <span class="h1">
          OVERVIEW
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, criteria for the classification of the idiopathic arthritides of childhood are intended to subdivide childhood-onset arthritides in a manner that allows for better understanding of their pathogenesis and treatment responses [
         <a href="#rid2">
          2,3
         </a>
         ].
        </p>
        <p>
         Juvenile arthritis classification criteria have been developed to measure the incidence of juvenile arthritis, understand its etiology, identify appropriate groups of patients for research, and group patients who may have similar responses to treatment and/or prognoses.
        </p>
        <p>
         It has become increasingly clear that many forms of JIA have a distinct etiology, pathogenesis, and natural history, which has led to refinements in classification criteria over time [
         <a href="#rid4">
          4-6
         </a>
         ].
        </p>
        <p>
         Many nomenclature systems include further "descriptors" within each category that are expected to result in additional subclassifications over time [
         <a href="#rid7">
          7,8
         </a>
         ]. While the initial purpose of these categories was to stratify patients enrolled in studies into homogeneous groups, this terminology is now also frequently used in clinical care to facilitate description of disease phenotype.
        </p>
        <p class="headingAnchor" id="H2752146488">
         <span class="h1">
          TERMINOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The classification and terminology of juvenile arthritis have evolved over time along with understanding of the disease. The older terms "juvenile rheumatoid arthritis" (JRA, used commonly in the United States) and "juvenile chronic arthritis" (JCA, preferred in Europe) were replaced by the term "juvenile idiopathic arthritis" (JIA) at meetings of the International League of Associations for Rheumatology (ILAR) in the late 1990s. JIA now incorporates all of what was called JRA in the past and also includes all other forms of "idiopathic" arthritis in childhood.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          JIA CLASSIFICATION CATEGORIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The International League of Associations for Rheumatology (ILAR) criteria for classification of the idiopathic arthritides of childhood are intended to define the separate childhood-onset arthritides in a manner that allows better evaluation of etiologic mechanisms and newer therapies [
         <a href="#rid2">
          2,3
         </a>
         ]. Despite limitations, these criteria are widely used in research in clinical care.
        </p>
        <p>
         Several reports have reinforced the idea that many of the children classified as having JIA in fact have early manifestations of what are recognized to be distinct diseases in adults (eg, systemic JIA and adult-onset Still's disease, polyarthritis [rheumatoid factor (RF) positive/RF-negative]/extended oligoarthritis and rheumatoid arthritis, and persistent oligoarthritis/enthesitis related arthritis and spondyloarthritis) [
         <a href="#rid9">
          9,10
         </a>
         ].
        </p>
        <p>
         Per the ILAR criteria, JIA is a diagnosis of exclusion [
         <a href="#rid11">
          11
         </a>
         ]. Disease onset is before 16 years of age, manifestations persist for at least six weeks, and the etiology is unknown. JIA is further categorized as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Systemic arthritis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Polyarthritis, RF positive or negative
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oligoarthritis, persistent or extended
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Enthesitis related arthritis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Psoriatic arthritis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Undifferentiated arthritis
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Systemic arthritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Systemic arthritis (systemic JIA) defines the category of patients that were previously labeled adult-onset Still's disease.
        </p>
        <p>
         Systemic arthritis is characterized by arthritis in one or more joints and fever of at least two weeks duration that is quotidian for at least three days. In addition, children must have one or more of the following findings: evanescent, erythematous rash; hepatomegaly or splenomegaly; lymph node enlargement; or serositis.
        </p>
        <p>
         This category is considered an autoinflammatory condition unrelated to other forms of childhood arthritis and requiring different therapy [
         <a href="#rid6">
          6
         </a>
         ]. Children with clearly identifiable syndromes associated with fever and arthritis, such as polyarteritis nodosa, are grouped separately. (See
         <a class="medical medical_review" href="/z/d/html/6401.html" rel="external">
          "Vasculitis in children: Incidence and classification"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6413.html" rel="external">
          "Systemic juvenile idiopathic arthritis: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6400.html" rel="external">
          "Systemic juvenile idiopathic arthritis: Treatment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13512.html" rel="external">
          "Systemic juvenile idiopathic arthritis: Course, prognosis, and complications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Polyarthritis, rheumatoid factor positive or negative
         </span>
         <span class="headingEndMark">
          —
         </span>
         The category of polyarthritis (polyarticular JIA) is defined by the presence of arthritis in five or more joints. This group is further divided according to the presence or absence of RF. (See
         <a class="medical medical_review" href="/z/d/html/6414.html" rel="external">
          "Polyarticular juvenile idiopathic arthritis: Clinical manifestations, diagnosis, and complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6428.html" rel="external">
          "Polyarticular juvenile idiopathic arthritis: Treatment"
         </a>
         .)
        </p>
        <p>
         According to the criteria as published, children should have at least two positive immunoglobulin M (IgM) RF tests at least three months apart, although, in practice, this test is often only obtained at baseline.
        </p>
        <p>
         Children with a first-degree relative with psoriasis, systemic arthritis, or features of enthesitis related arthritis are excluded from the category of polyarthritis.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Oligoarthritis, persistent or extended
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oligoarthritis (oligoarticular JIA) defines the subset of patients that were previously labeled as pauciarticular JRA (see
         <a class="medical medical_review" href="/z/d/html/6415.html" rel="external">
          "Oligoarticular juvenile idiopathic arthritis"
         </a>
         ). These patients have less than five joints involved at diagnosis and are further categorized as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Persistent oligoarthritis refers to children with one to four joints affected during the first six months of disease who do not develop arthritis in five or more joints during their disease course.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Extended oligoarthritis refers to children with less than five joints affected during the first six months of disease who subsequently experience involvement of more than four joints.
        </p>
        <p>
        </p>
        <p>
         Children with a positive RF, a first-degree relative with psoriasis, features of enthesitis related arthritis, or systemic arthritis are excluded from these categories.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Enthesitis related arthritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The category of enthesitis related arthritis is applied to children with both arthritis and enthesitis, arthritis alone, or enthesitis alone and two or more of the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sacroiliac joint tenderness or lumbosacral inflammatory pain
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Positive human leukocyte antigen (HLA)-B27
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         First-degree relative with acute anterior uveitis, ankylosing spondylitis, inflammatory bowel disease with sacroiliitis, or reactive arthritis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute anterior uveitis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Onset of arthritis in males &gt;6 years of age
        </p>
        <p>
        </p>
        <p>
         Children are excluded from this category if they have a first-degree relative with psoriasis, positive RF, or systemic arthritis.
        </p>
        <p>
         This category includes some children previously diagnosed with spondyloarthropathies (see
         <a class="medical medical_review" href="/z/d/html/6421.html" rel="external">
          "Spondyloarthritis in children"
         </a>
         ), as well as some children likely to develop psoriatic arthritis (see
         <a class="medical medical_review" href="/z/d/html/16630.html" rel="external">
          "Psoriatic juvenile idiopathic arthritis: Pathogenesis, clinical manifestations, and diagnosis"
         </a>
         ) who lack sufficient criteria at the time of diagnosis. In fact, classification of spondyloarthropathies in the adult literature is advancing rapidly with the clear recognition that these diseases are unrelated to other forms of arthritis [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Psoriatic arthritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Psoriatic arthritis is defined as children with psoriasis and arthritis or children with arthritis and two of the following [
         <a href="#rid12">
          12
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/16630.html" rel="external">
          "Psoriatic juvenile idiopathic arthritis: Pathogenesis, clinical manifestations, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16366.html" rel="external">
          "Psoriatic juvenile idiopathic arthritis: Management and prognosis"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Psoriasis in a first-degree relative
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dactylitis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Appropriate fingernail abnormalities (eg, pitting or onycholysis)
        </p>
        <p>
        </p>
        <p>
         Children are excluded from this category if they have features of enthesitis related arthritis, systemic arthritis, or positive RF.
        </p>
        <p class="headingAnchor" id="H3682911603">
         <span class="h2">
          Undifferentiated arthritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children are categorized as undifferentiated if they do not meet criteria for one of the categories above due to incomplete features or the presence of exclusions. Children are also considered undifferentiated if they meet criteria for more than one category.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          APPLICABILITY OF THE ILAR CRITERIA
         </span>
         <span class="headingEndMark">
          —
         </span>
         To determine the usefulness of the International League of Associations for Rheumatology (ILAR) classification criteria, 194 children with arthritis of more than six months' duration were assessed [
         <a href="#rid13">
          13
         </a>
         ]. Eighty percent of the children could be categorized. Among the difficult-to-classify children, approximately one-half did not satisfy criteria for any specific category, although the remainder met criteria for more than one category. As an example, eight children could be categorized as having both enthesitis related arthritis and rheumatoid factor (RF) negative polyarthritis.
        </p>
        <p class="headingAnchor" id="H2709974146">
         <span class="h1">
          ONGOING RESEARCH INTO JIA CLASSIFICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The classification of juvenile arthritis is an area of active research and is continuing to evolve along with improved understanding of the biologic heterogeneity of the disease. Alternative classification systems have been suggested based upon evolving understanding of disease phenotypes, cytokine profiles, and genetics [
         <a href="#rid14">
          14
         </a>
         ]. These various classification systems require additional biologic and prospective validation to determine their utility.
        </p>
        <p>
         Many patients in the pediatric JIA categories share similar genetics to adult patients with arthritis and therefore represent a spectrum of arthritis, rather than separate entities. An overview of these genetic similarities proposed four primary categories based upon these patterns [
         <a href="#rid15">
          15
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seropositive (rheumatoid factor [RF] positive) arthritis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seronegative (RF-negative) arthritis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spondyloarthritis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Systemic arthritis
        </p>
        <p>
        </p>
        <p>
         A consensus conference led by the Pediatric Rheumatology International Trials Organization (PRINTO) proposed a revision to the existing categories based upon Delphi and nominal group methodologies [
         <a href="#rid16">
          16
         </a>
         ]. The categories resulting from this project include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Systemic JIA
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         RF-positive JIA
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Early-onset antinuclear antibody (ANA) positive JIA
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Enthesitis/spondylitis-related JIA
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H149188132">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112604.html" rel="external">
          "Society guideline links: Juvenile idiopathic arthritis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H260371566">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/83288.html" rel="external">
          "Patient education: Juvenile idiopathic arthritis (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Overview
         </strong>
         – The classification of juvenile idiopathic arthritis (JIA) remains a challenging area given the heterogeneity of the disease. Classification criteria are intended for use in the research setting, and not as diagnostic criteria to be used at the bedside, but may still have utility in helping providers communicate about disease features, treatment options, and prognosis. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Overview'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          ILAR classification categories for JIA
         </strong>
         – The International League of Associations for Rheumatology (ILAR) state that JIA is a diagnosis of exclusion. Disease onset is before 16 years of age, manifestations persist for at least six weeks, and the etiology is unknown. (See
         <a class="local">
          'JIA classification categories'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         JIA is further categorized as follows:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Systemic arthritis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Polyarthritis, rheumatoid factor (RF) positive or negative
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Oligoarthritis, persistent or extended
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Enthesitis related arthritis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Psoriatic arthritis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Undifferentiated arthritis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Future classification schemes
         </strong>
         – The ILAR criteria are considered the standard, and any proposed new systems still require further validation. With improving genetic and pathophysiologic understanding of arthritis, it is hoped that future classification schemes will define homogeneous collections of children with biologically distinct illnesses. (See
         <a class="local">
          'JIA classification categories'
         </a>
         above and
         <a class="local">
          'Ongoing research into JIA classification'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2825842239">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate acknowledge Thomas JA Lehman, MD and Sarah Ringold, MD, MS, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Aggarwal R, Ringold S, Khanna D, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken) 2015; 67:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fink CW. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J Rheumatol 1995; 22:1566.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25:1991.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yasser R, Yasser E, Hanan D, et al. Enthesitis in seronegative spondyloarthropathies with special attention to the knee joint by MRI: a step forward toward understanding disease pathogenesis. Clin Rheumatol 2011; 30:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tam LS, Gu J, Yu D. Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 2010; 6:399.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet 2011; 377:2138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ravelli A, Varnier GC, Oliveira S, et al. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheum 2011; 63:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnes MG, Grom AA, Thompson SD, et al. Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis. Arthritis Rheum 2010; 62:3249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ombrello MJ, Arthur VL, Remmers EF, et al. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis 2017; 76:906.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oliveira-Ramos F, Eusébio M, M Martins F, et al. Juvenile idiopathic arthritis in adulthood: fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damage. RMD Open 2016; 2:e000304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flatø B, Lien G, Smerdel-Ramoya A, Vinje O. Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis. J Rheumatol 2009; 36:642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hofer MF, Mouy R, Prieur AM. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. J Rheumatol 2001; 28:1083.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eng SW, Duong TT, Rosenberg AM, et al. The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis. Arthritis Rheumatol 2014; 66:3463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nigrovic PA. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheumatol 2014; 66:1405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martini A, Ravelli A, Avcin T, et al. Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. J Rheumatol 2019; 46:190.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6412 Version 23.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25776731" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Distinctions between diagnostic and classification criteria?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7473484" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Proposal for the development of classification criteria for idiopathic arthritides of childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9779856" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21210292" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Enthesitis in seronegative spondyloarthropathies with special attention to the knee joint by MRI: a step forward toward understanding disease pathogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20517295" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Pathogenesis of ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21684384" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Juvenile idiopathic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20936630" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20662067" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27927641" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27752356" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Juvenile idiopathic arthritis in adulthood: fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14760812" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19208605" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11361194" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25200124" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24623686" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30275259" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
